Sentinel node biopsy procedures with an analysis of recurrence patterns and prognosis in melanoma patients: technical advantages using computer-assisted gamma probe with adjustable collimation

被引:20
作者
Borgognoni, L
Urso, C
Vaggelli, L
Brandani, P
Gerlini, G
Reali, UM
机构
[1] St M Annunziata Hosp, Reg Melanoma Referral Ctr, Plast Surg Unit, I-50011 Florence, Italy
[2] St M Annunziata Hosp, Anat Pathol Dermatol Sect, I-50011 Florence, Italy
[3] Careggi Hosp, Florence, Italy
关键词
melanoma; sentinel node; probe; interval nodes; recurrences; prognosis;
D O I
10.1097/01.cmr.0000133968.28172.6e
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to investigate whether a computer-assisted gamma probe with adjustable collimation could aid in the detection of sentinel nodes (SNs) and to analyse the patterns of recurrence and prognosis in SN-positive and SN-negative cases. We analysed 385 SN biopsies. The SN identification rate was 87.2% using preoperative lymphoscintigraphy and blue dye, 93.9% using preoperative lymphoscintigraphy, blue dye and different probes, and 100% using preoperative lymphoscintigraphy, blue dye and a computer-assisted probe with adjustable collimation. The computer-assisted probe was particularly advantageous in cases where the melanoma was located very close to the SN and in cases of deep-seated nodes or nodes with low uptake, due to the possibility of changing the collimation during the procedure. The SN-positive rate according to the thickness of the primary melanoma was 1.7% for melanomas less than or equal to 1 mm in thickness and 27.5% for melanomas greater than or equal to 1 mm. In 4.9% of cases we identified nodes outside the regional nodal basin. In one case we found a micrometastasis in a blue and hot interval node of the metastases was not the most radioactive node in the field in six out of 52 positive cases (11.5%). Distant metastases were present in 2.0% of SN-negative patients, and in 24% of SN-positive patients (P<0.001). Highly statistically significant differences were found between SN-negative and SN-positive patients in both the 3 year disease-free survival (86.3% versus 49.2%) and the 3 year disease-specific survival (92.3% versus 77.1%) (P<0.001). (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:311 / 319
页数:9
相关论文
共 45 条
[1]   GAMMA-PROBE-GUIDED LYMPH-NODE LOCALIZATION IN MALIGNANT-MELANOMA [J].
ALEX, JC ;
WEAVER, DL ;
FAIRBANK, JT ;
RANKIN, BS ;
KRAG, DN .
SURGICAL ONCOLOGY-OXFORD, 1993, 2 (05) :303-308
[2]   HMB-45 immunohistochemical staining of sentinel lymph nodes - A specific method for enhancing detection of micrometastases in patients with melanoma [J].
Baisden, BL ;
Askin, FB ;
Lange, JR ;
Westra, WH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (08) :1140-1146
[3]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[4]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[5]   Gamma-probe-directed lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma [J].
Belhocine, T ;
Piérard, GE ;
Gielen, JL ;
Daenen, F ;
De Barsy, C ;
Arrese, JE ;
Lahaye, T ;
Rigo, P .
DERMATOLOGY, 2002, 204 (04) :355-361
[6]   Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins [J].
Bostick, P ;
Essner, R ;
Glass, E ;
Kelley, M ;
Sarantou, T ;
Foshag, LJ ;
Qi, K ;
Morton, D .
ARCHIVES OF SURGERY, 1999, 134 (01) :43-49
[7]   Vital dyes in sentinel node localization [J].
Bostick, PJ ;
Giuliano, AE .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (01) :18-24
[8]   Update on the use of sentinel node biopsy in patients with melanoma: who and how [J].
Chao, C ;
McMasters, KM .
CURRENT OPINION IN ONCOLOGY, 2002, 14 (02) :217-220
[9]   Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence [J].
Clary, BM ;
Brady, MS ;
Lewis, JJ ;
Coit, DG .
ANNALS OF SURGERY, 2001, 233 (02) :250-258
[10]   The pathologist's role in sentinel lymph node evaluation [J].
Cochran, AJ .
SEMINARS IN NUCLEAR MEDICINE, 2000, 30 (01) :11-17